The Medicines Company Indenture Agreements

7 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Supplemental Indenture to 3.50% Convertible Senior Notes Due 2024 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
First Supplemental Indenture to 2.75% Convertible Senior Notes Due 2023 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
First Supplemental Indenture to 2.50% Convertible Senior Notes Due 2022 – The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2020
Indenture Agreement for 3.50% Convertible Senior Notes due 2024 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2018
Indenture for 2.75% Convertible Senior Notes due 2023 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2016
Indenture for 2.50% Convertible Senior Notes due 2022 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
DE
2015
Indenture for 1.375% Convertible Senior Notes due 2017 between The Medicines Company and Wells Fargo Bank, N.A.
Indenture Agreements
The Medicines Company
Pharmaceuticals
NY
2012